C. L. Lancashire

651 total citations
17 papers, 549 citations indexed

About

C. L. Lancashire is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, C. L. Lancashire has authored 17 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 6 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in C. L. Lancashire's work include Neuroscience and Neuropharmacology Research (9 papers), Alzheimer's disease research and treatments (6 papers) and Genetics and Neurodevelopmental Disorders (3 papers). C. L. Lancashire is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Alzheimer's disease research and treatments (6 papers) and Genetics and Neurodevelopmental Disorders (3 papers). C. L. Lancashire collaborates with scholars based in United Kingdom, Greece and Russia. C. L. Lancashire's co-authors include Radmila Mileusnić, S. P. R. Rose, Susan W. Craig, Amy N.B. Johnston, Steven P. R. Rose, John A. Cooper, Jane Loughlin, Geraldine Flynn, David Male and Karen Holloway and has published in prestigious journals such as The Journal of Cell Biology, Annals of the New York Academy of Sciences and Neuroscience.

In The Last Decade

C. L. Lancashire

17 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. L. Lancashire United Kingdom 13 173 172 122 79 71 17 549
Michael Reiser Germany 15 139 0.8× 289 1.7× 177 1.5× 44 0.6× 126 1.8× 31 700
Armen A. Galoyan Armenia 14 253 1.5× 372 2.2× 162 1.3× 24 0.3× 97 1.4× 42 786
Michael S. Poosch United States 14 416 2.4× 524 3.0× 94 0.8× 55 0.7× 60 0.8× 19 893
Thomas Suply Switzerland 15 169 1.0× 361 2.1× 142 1.2× 121 1.5× 93 1.3× 17 962
Megan Libbey United States 6 156 0.9× 177 1.0× 44 0.4× 110 1.4× 23 0.3× 6 414
M.P. Roisin France 18 464 2.7× 533 3.1× 74 0.6× 101 1.3× 48 0.7× 27 982
Brad Busse United States 12 278 1.6× 255 1.5× 56 0.5× 102 1.3× 23 0.3× 17 696
H. Koppel United Kingdom 11 197 1.1× 221 1.3× 59 0.5× 50 0.6× 34 0.5× 21 598
Mengping Wei China 13 223 1.3× 451 2.6× 106 0.9× 78 1.0× 30 0.4× 27 904
Ruiyu Wang China 15 226 1.3× 541 3.1× 62 0.5× 125 1.6× 66 0.9× 37 1.0k

Countries citing papers authored by C. L. Lancashire

Since Specialization
Citations

This map shows the geographic impact of C. L. Lancashire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. L. Lancashire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. L. Lancashire more than expected).

Fields of papers citing papers by C. L. Lancashire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. L. Lancashire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. L. Lancashire. The network helps show where C. L. Lancashire may publish in the future.

Co-authorship network of co-authors of C. L. Lancashire

This figure shows the co-authorship network connecting the top 25 collaborators of C. L. Lancashire. A scholar is included among the top collaborators of C. L. Lancashire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. L. Lancashire. C. L. Lancashire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Holloway, Karen, Geraldine Flynn, C. L. Lancashire, et al.. (2008). Chemokine production and chemokine receptor expression by human glioma cells: Role of CXCL10 in tumour cell proliferation. Journal of Neuroimmunology. 199(1-2). 35–45. 91 indexed citations
2.
Mileusnić, Radmila, C. L. Lancashire, Jonathan Clark, & Steven P. R. Rose. (2007). Protection against Aβ-induced memory loss by tripeptide D-Arg-L-Glu-L-Arg. Behavioural Pharmacology. 18(3). 231–238. 14 indexed citations
3.
Mileusnić, Radmila, C. L. Lancashire, & Steven Rose. (2006). O3–05–02: Peptidomimetics derived from the amyloid precursor protein (APP) as potential therapeutic agents in Alzheimer's disease. Alzheimer s & Dementia. 2(3S_Part_3). 1 indexed citations
4.
Mileusnić, Radmila, C. L. Lancashire, & Steven P. R. Rose. (2005). Recalling an aversive experience by day-old chicks is not dependent on somatic protein synthesis. Learning & Memory. 12(6). 615–619. 20 indexed citations
5.
Rodrı́guez-Álvarez, José, Heather A. Davies, Christopher J. Peddie, et al.. (2005). Long‐term potentiation in the rat dentate gyrus is associated with enhanced Arc/Arg3.1 protein expression in spines, dendrites and glia. European Journal of Neuroscience. 21(9). 2384–2396. 93 indexed citations
6.
Mileusnić, Radmila, C. L. Lancashire, & Steven P. R. Rose. (2005). Amyloid Precursor Protein: From Synaptic Plasticity to Alzheimer's Disease. Annals of the New York Academy of Sciences. 1048(1). 149–165. 11 indexed citations
7.
Rodrı́guez-Álvarez, José, Heather A. Davies, Christopher J. Peddie, et al.. (2005). Long‐term potentiation in the rat dentate gyrus is associated with enhanced Arc/Arg3.1 protein expression in spines, dendrites and glia. European Journal of Neuroscience. 22(5). 1264–1264. 1 indexed citations
8.
Mileusnić, Radmila, C. L. Lancashire, & S. P. R. Rose. (2004). The peptide sequence Arg‐Glu‐Arg, present in the amyloid precursor protein, protects against memory loss caused by Aβ and acts as a cognitive enhancer. European Journal of Neuroscience. 19(7). 1933–1938. 32 indexed citations
9.
Dermon, Catherine R., et al.. (2002). Passive avoidance training enhances cell proliferation in 1‐day‐old chicks. European Journal of Neuroscience. 16(7). 1267–1274. 22 indexed citations
10.
Mileusnić, Radmila, C. L. Lancashire, Amy N.B. Johnston, & S. P. R. Rose. (2000). APP is required during an early phase of memory formation. European Journal of Neuroscience. 12(12). 4487–4495. 28 indexed citations
11.
Mileusnić, Radmila, C. L. Lancashire, Amy N.B. Johnston, & S. P. R. Rose. (2000). APP is required during an early phase of memory formation. European Journal of Neuroscience. 12(12). 4487–4495. 57 indexed citations
12.
Mileusnić, Radmila, C. L. Lancashire, & Steven P. R. Rose. (1999). Sequence-Specific Impairment of Memory Formation by NCAM Antisense Oligonucleotides. Learning & Memory. 6(2). 120–127. 17 indexed citations
13.
Sandi, Carmen, S. P. R. Rose, Radmila Mileusnić, & C. L. Lancashire. (1995). Corticosterone facilitates long-term memory formation via enhanced glycoprotein synthesis. Neuroscience. 69(4). 1087–1093. 49 indexed citations
14.
Foster, Keith, Kingsley Micklem, Gudrún Agnarsdóttir, et al.. (1983). Myxoviruses do not induce non-specific alterations in membrane permeability early on in infection. Archives of Virology. 77(2-4). 139–153. 9 indexed citations
15.
Craig, Susan W., C. L. Lancashire, & John A. Cooper. (1982). [29] Preparation of smooth muscle α-actinin. Methods in enzymology on CD-ROM/Methods in enzymology. 85 Pt B. 316–321. 44 indexed citations
16.
Craig, Susan W. & C. L. Lancashire. (1980). Comparison of intestinal brush-border 95-Kdalton polypeptide and alpha-actinins.. The Journal of Cell Biology. 84(3). 655–667. 37 indexed citations
17.
Atkins, Gerald J. & C. L. Lancashire. (1976). The Induction of Interferon by Temperature-Sensitive Mutants of Sindbis Virus: Its Relationship to Double-Stranded RNA Synthesis and Cytopathic Effect. Journal of General Virology. 30(2). 157–165. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026